Zentalis Pharmaceuticals ZNTL Cash Flow Statement (2019-2026)

NASDAQ ZNTL
$3.99 -0.12 (-2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Zentalis Pharmaceuticals Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Zentalis Pharmaceuticals reported cash from operations of -$37.24M and free cash flow of -$37.24M for the quarter ended Jun 2026, down 7.3% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.49M-48.26M-57.49M-63.05M-52.13M-48.16M-60.95M-98.86M-55.54M-60.94M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M-35.22M-35.35M-42.29M
Share-based Compensation
7.66M17.35M10.15M16.76M10.32M9.61M13.73M13.34M13.87M13.88M12.83M12.71M10.36M31.36M6.49M6.29M4.83M3.12M3.20M3.21M
Deferred Taxes
-0.07M0.07M-0.77M-0.10M-0.76M
Asset Writedowns and Impairment
4.95M1.15M2.98M
Cash from Operations
-33.49M-37.02M-50.20M-43.03M-33.20M-37.33M-49.28M-79.28M-38.66M-40.60M-51.97M-35.14M-44.05M-39.70M-32.64M-34.71M-26.96M-30.94M-32.96M-37.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-1.23M-0.20M-0.15M0.13M1.27M2.48M3.26M3.22M2.12M4.55M2.76M2.20M1.65M1.40M1.03M0.78M0.52M0.43M0.22M0.05M
Depreciation & Amortization (CF)Depreciation & Amortization
0.14M0.21M0.34M0.35M0.38M0.33M0.36M0.34M0.35M0.30M0.32M0.33M0.32M0.33M0.26M0.16M0.16M0.16M0.15M0.15M
Change in Working Capital
Change in Receivables
0.10M-0.10M0.00M5.00M-5.00M
Change in Accured Expenses
7.47M1.65M-0.50M4.53M6.45M5.05M-1.41M-4.39M6.33M10.40M-15.25M11.80M-12.01M-2.56M-4.02M-10.58M-1.98M-0.73M-1.45M2.26M
Other Working Capital Changes
-5.22M0.40M4.15M2.51M-1.95M1.89M2.92M1.00M1.28M0.48M1.06M-1.61M-5.44M-0.23M-0.66M-2.35M-0.68M0.70M-0.97M0.37M
Investing Activities
Capital Expenditures
2.66M2.19M0.45M0.28M1.66M0.16M0.32M0.09M0.17M0.04M0.18M0.03M
Sales of Property, Plant and Equipment
0.07M0.01M0.56M0.13M
Change in Acquisitions & Divestments
78.01M128.68M99.50M56.50M151.28M114.25M106.00M198.46M146.75M54.10M71.70M54.00M74.00M71.50M60.00M70.00M60.00M60.00M60.00M60.00M
Cash from Investing Activities
-141.44M43.27M19.80M-142.10M20.02M-11.89M42.12M72.93M-117.45M-42.06M61.55M34.49M48.24M32.28M40.48M30.38M28.32M32.45M30.01M30.02M
Financing Activities
Other financing activities
3.65M3.66M1.26M0.16M0.59M1.12M0.37M0.94M0.31M0.25M0.01M0.09M0.19M0.12M0.33M0.07M
Change in Capital Stock
Net Equity Issued and Repurchased
162.22M9.75M184.30M48.62M
Misc.
Cash from Financing Activities
166.57M12.27M1.26M209.46M0.59M49.74M0.37M236.62M0.31M0.01M0.01M0.09M0.19M0.12M-4.59M-1.12M0.07M
Change in Cash
-8.36M18.51M-29.14M24.33M-12.59M0.52M-6.79M230.28M-155.81M-82.66M9.58M-0.64M4.29M-7.42M8.03M-4.33M1.47M-3.08M-4.07M-7.15M
Free Cash Flow
-36.15M-39.21M-50.65M-43.30M-34.86M-37.49M-49.28M-79.59M-38.76M-40.77M-52.01M-35.32M-44.05M-39.70M-32.64M-34.71M-26.96M-30.94M-32.99M-37.24M
Net Cash Flow
-8.36M18.51M-29.14M24.33M-12.59M0.52M-6.79M230.28M-155.81M-82.66M9.58M-0.64M4.29M-7.42M8.03M-4.33M1.47M-3.08M-4.07M-7.15M